Phytosphingosine
111 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
111
Total Reports
2
Deaths Reported
180.0%
Death Rate
Active Ingredients
Phytosphingosine
Administration Routes
TopicalUnknownAuricular (Otic)OralNasalCutaneous
Species Affected
Dog 96
Cat 8
Human 6
Rabbit 1
Most Affected Breeds
Retriever - Golden 7
Crossbred Canine/dog 7
Terrier - Yorkshire 7
Unknown 6
Bulldog 5
Retriever - Labrador 5
Spaniel - Cocker American 4
Pit Bull 4
Shepherd Dog - German 4
Chihuahua 4
Most Reported Reactions
Vomiting 15
Pruritus 13
Lack of efficacy - NOS 13
Erythema (for urticaria see Immune SOC) 11
Behavioural disorder NOS 10
Other abnormal test result NOS 10
Diarrhoea 9
Lethargy (see also Central nervous system depression in 'Neurological') 8
Hives (see also 'Skin') 7
Ear discharge 7
Alopecia local 7
Unclassifiable adverse event 6
Outcome Breakdown
Recovered/Normal
42 (39.6%)
Outcome Unknown
31 (29.2%)
Ongoing
24 (22.6%)
Recovered with Sequela
7 (6.6%)
Died
1 (0.9%)
Euthanized
1 (0.9%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.